This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Enara Bio Limited, The Francis Crick Institute Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 11 Years Active: 2025
Title: David Perkins: Innovator in Cancer Research
Introduction
David Perkins is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the development of cancer antigens and methods for their application in treatment and diagnosis.
Latest Patents
David Perkins holds a patent related to cancer antigens. This patent includes polypeptides and nucleic acids encoding these polypeptides, which are useful in the treatment, prevention, and diagnosis of cancer, especially melanoma, including cutaneous melanoma and uveal melanoma. He has 1 patent to his name.
Career Highlights
Throughout his career, David has worked with prominent organizations such as the Francis Crick Institute Limited and Enara Bio Limited. His work has focused on advancing the understanding and treatment of cancer, contributing to innovative solutions in the medical field.
Collaborations
David has collaborated with esteemed colleagues, including George Kassiotis and George Young. These partnerships have further enhanced his research and development efforts in cancer treatment.
Conclusion
David Perkins is a dedicated inventor whose work in cancer research has the potential to make a significant impact on the treatment and diagnosis of melanoma. His contributions continue to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile